Back to Journals » Clinical Epidemiology » Volume 2

The Nordic health registers – an important source when evaluating the safety of antidepressants during pregnancy

Authors Kieler H

Published 24 August 2010 Volume 2010:2 Pages 205—207

DOI https://doi.org/10.2147/CLEP.S10426


Helle Kieler
Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Abstract: Depression during pregnancy occurs frequently and selective serotonin reuptake inhibitors (SSRIs) are often the drug of choice when treating pregnant women. Most published studies found no increased risks of congenital malformations in association with SSRIs, but there are reports of various malformations for SSRIs as a group and for specific SSRIs. To assess potential adverse effects of SSRIs as one group may be questioned because of their dissimilarities and very large datasets are needed when studying specific SSRIs. The national health and population registers in the Nordic countries offer excellent opportunities to assess long term effects of exposure during fetal life. As each of the Nordic countries is small, collaborative studies including information from all the Nordic countries are warranted to fully understand risks associated with exposure to antidepressants in fetal life.

Keywords: antidepressive agents, adverse effect, pregnancy, multicenter study

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]